+P5 (D1S3309E), a novel target binding site for the Wilms’ tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21→q22

Cytogenetics and Cell Genetics

Volumn 72, Issue 4, 1996, Pages 306-309

  Negus, K ^a   Holmes, G H ^a   Wicking, C ^a   Wainwright, B J ^a   Little, M H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING SITE; CHROMOSOME 1Q; DNA BINDING; GENE LOCATION; HUMAN; HUMAN CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; COSMIDS; DNA; DNA PRIMERS; DNA-BINDING PROTEINS; GENES, WILMS TUMOR; HUMANS; HYBRID CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; WT1 PROTEINS; ZINC FINGERS;

EID: 0029987835     PISSN: 03010171     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000134210     Document Type: Article

References (24)

1. Bickmore WA, Oghene K, Little MH, Seawrighl A, Heyningen V van, Mastic ND: Modulation of DN'A binding specificity by alternative splicing of the Wilms' tumor WT1 gene transcript. Science 257:235-237 (1992).
2. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose HA, Krai A, Yegcr H, Lewis WH, Jones C, Housman DE: Isolation and characterisation of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell 60:509-520(1990).
3. Choo KM, Filhv G, Greco S, Lan V-F, Kan YW: Cos-mid vectors for high efficiency DNA-mediated transformation and gene amplification in mammalian cells: studies with the human growth hormone gene. Gene 46:277-286 (1986).
4. Coppes MJ, Campbell CF, Williams BRG: The role of WTl in Wilms tumorigenesis. FASEB J 7:886-895 (1993).
5. Gessler M, Poutska A, Cavcnee W, Neve RL, Orkin SH, Bruns GAP: Homozygous deletion in Wilms tumours of a zinc-fingcr gene identified by chromosome jumping. Nature 343:774-778 (1990).
6. Grundy P, Koulos A, Morgan K, Li FP, Meadows A, Cavenee WK: Familial predisposition to Wilms’ tumour does not map to the short arm of chromosome 11. Nature 336:374-376 (1988).
7. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE: An internal deletion w ithin an 11 pi 3 zinc finger gene contributes to the development of Wilms' tumor. Cell 61:1257-1269(1990).
8. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE: Alternative splicing and genomic structure of the Wilms’ tumor gene WTl. Proc natl Acad Set. USA 88:9618-9622 (1991).
9. Huff V, Compton DA, Chao LY, Strong LC, Geiser CF, Saunders GF: Lack of linkage of familial Wilms' tumour to chromosomal band 11 p 13. Nature 336:377-378(1988).
10. Huff V, Reeve AE, Leppert VI, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G, Saunders GF: Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res 52:6117-6120 (1992).
11. Knudson AG, Strong LC: Mutation and cancer: a model for Wilms' tumor of the kidney. J natl Cancer Inst 48:313-324(1972).
12. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jacnisch R: WT-I is required for early kidney development. Cell 74:679-691 (1993).
13. Kugoh H, Nakagawa Y, Mitsuya K, Mita T, Suzuki M, Suzuki N, Uejima H, Yuasa Y, Oshimura M: Isolation and mapping of 186 new DNA markers on human chromosome I. Genomics 27:207-210 (1995).
14. Little MH, Byrne J, Clarke J, Dunn R, Smith PJ: Allelic loss on chromosome 11 p is a less frequent event in bilateral than in unilateral tumours. Eur J Cancer 28A: 1879-1883(1992a).
15. Little MH, Prosser J, Condie A, Smith PJ, Heyningen V van, Hastie ND: Zinc finger point mutations within the WTl gene in Wilms' tumor patients. Proc natl Acad Sei. USA 89:4791-4795 (1992b).
16. Maw M, Grundy P, Millow LJ, Eccles M, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Callen DF, Thompson AD, Richards RL, Reeve AE: A third Wilms’ tumor loeus on chromosome 16q. Cancer Res 52:3094-3098 (1992).
17. Pelletier J, Bmcning W, Li FP, Haber DA, Glaser T, Housman DE: WTl mutation contributed abnormal genital system development and hereditary Wilms’ tumor. Nature 353:431-434(1991).
18. Rauscher FJ III: The WTl Wilms’ tumor gene product: a developmentally regulated transacription factor in the kidney that functions as a tuntor suppressor. FASEB J 7:896-903(1993).
19. Reeve AE, Sih SV, Raizis AM, Feinherg AP: Loss of allelic heterozygosity at a second loeus on chromosome 11 in sporadic Wilms' tumor cells. Mol cell Biol 9:1799-1803(1989).
20. 7:90-94(1989).
21. Slater RM, Mannens MM, Y Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogcnel 61:111-121 (1992).
22. Solomon E: Recessive mtation in aetiology of Wilms’ tumour. Nature 309:111-112(1984).
23. Szabo J, Heath B, Hill YM, Jackson CE, Zarbo RJ, Malletle LE, Chew SL, Bcsser GM, Tnakker RY, Huff V, Leppert ME, Heath H: Hereditary hvper-parathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome lq2I-.3l. Am J hum Genet56:944-950 (1995).
24. Wicking C, Breen M, Negus K, Beikman J, Evdokiou A, Cowled P, Chenmevix-Trcnch G, Wainwright B: The human-growth-spccific gene GAS 1 maps outside the candidate region of the gene for nevoid basal cell carcinoma syndrome. Cylogenet Cell Genet 68:119-121 (1995).